Breadcrumb Home investors investor resources Investor Resources Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-20182016-20172015-2016 Apply Appointment of Senior Management Personnel 15th Mar 2024 Allotment of 1,658 equity shares under ESOS 2013-A Scheme and Cipla ESAR Scheme 2021 of the Company 15th Mar 2024 Sale of entire stake in Wellthy Therapeutics Private Limited 06th Mar 2024 Schedule of Analyst / Institutional Investor Meetings 06th Mar 2024 GST order received from Office of the Joint Commissioner, Large Taxpayer Unit, Corporate Division, West Bengal 06th Mar 2024 Schedule of Analyst / Institutional Investor Meetings 05th Mar 2024 Update on transfer of Generics Business Undertaking of the Company to Cipla Pharma and Life Sciences Limited, wholly owned subsidiary 01st Mar 2024 Update on incorporation of a joint venture company in USA 01st Mar 2024 USFDA inspection at manufacturing facility in Qidong, Jiangsu Province, China 01st Mar 2024 Intimation for Loss of Share Certificates 01st Mar 2024 + BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.